P030040S001

None

FDA Premarket Approval P030040 S001

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP030040S001
Classification NameNone
Applicant
PMAP030040
SupplementS001

Supplemental Filings

Supplement NumberDateSupplement Type
P030040Original Filing
S021 2022-03-22 30-day Notice
S020 2021-04-01 30-day Notice
S019 2020-12-22 Real-time Process
S018 2020-07-31 30-day Notice
S017 2020-03-09 30-day Notice
S016 2020-02-21 30-day Notice
S015 2019-02-01 30-day Notice
S014 2018-08-15 Normal 180 Day Track No User Fee
S013 2018-07-19 Real-time Process
S012 2017-06-16 Normal 180 Day Track
S011 2016-07-05 Normal 180 Day Track
S010 2015-06-11 30-day Notice
S009 2015-05-14 Normal 180 Day Track
S008 2012-03-26 Normal 180 Day Track No User Fee
S007 2010-02-18 30-day Notice
S006 2009-05-18 Normal 180 Day Track
S005 2009-03-31 Normal 180 Day Track
S004 2009-03-09 Normal 180 Day Track No User Fee
S003 2009-02-04 30-day Notice
S002 2008-08-11 Normal 180 Day Track
S001

NIH GUDID Devices

Device IDPMASupp
00630414978017 P030040 000
00630414597805 P030040 000
00630414470504 P030040 000
00630414597799 P030040 002
00630414470498 P030040 002
00630414301266 P030040 002

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.